Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination

References

• Ahuja M, Sharma SK, Majumdar DK. (2007). In vitro corneal permeation of diclofenac from oil drops. Yakugaku Zasshi 127:1739–45
   PubMed Web of Science ®Google Scholar
• Akhtar N, Rehman MU, Khan HMS, et al. (2011). Penetration enhancing effect of polysorbate 20 and 80 on the in vitro percutaneous absorption of L-ascorbic acid. Trop J Pharm Res 10:281–8
   Web of Science ®Google Scholar
• Alany RG, Rades T, Nicoll J, et al. (2006). W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. J Control Release 111:145–52
   PubMed Web of Science ®Google Scholar
• Araujo J, Gonzalez-Mira E, Egea MA, et al. (2010). Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 393:167–75
   PubMed Web of Science ®Google Scholar
• Araujo J, Vega E, Lopes C, et al. (2009). Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces 72:48–56
   PubMed Web of Science ®Google Scholar
• Attama AA, Reichl S, Muller-Goymann CC. (2008). Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 355:307–13
   PubMed Web of Science ®Google Scholar
• Attama AA, Schicke BC, Paepenmuller T, Muller-Goymann CC. (2007). Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization. Eur J Pharm Biopharm 67:48–57
   PubMed Web of Science ®Google Scholar
• Bassetti M, Dembry LM, Farrel PA, et al. (2001). Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria. Diagn Microbiol Infect Dis 41:143–8
   PubMed Web of Science ®Google Scholar
• Benita S, Levy MY. (1993). Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. J Pharm Sci 82:1069–79
   PubMed Web of Science ®Google Scholar
• Blondeau JM. (2004). Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol 49:S73–8
   PubMed Web of Science ®Google Scholar
• Chan J, Maghraby GM, Craig JP, Alany RG. (2007). Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation. Int J Pharm 328:65–71
   PubMed Web of Science ®Google Scholar
• Driscoll DF, Etzler F, Barber TA, et al. (2001). Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction. Int J Pharm 219:21–37
   PubMed Web of Science ®Google Scholar
• Ezrahi S, Tuval E, Aserin A, Garti N. (2005). The effect of structural variation of alcohols on water solubilization in nonionic microemulsions 1. From linear to branched amphiphiles – general considerations. J Colloid Interface Sci 291:263–72
   PubMed Web of Science ®Google Scholar
• Felt O, Furrer P, Mayer JM, et al. (1999). Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm 180:185–93
   PubMed Web of Science ®Google Scholar
• Fialho SL, da Silva-Cunha A. (2004). New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Experiment Ophthalmol 32:626–32
   PubMed Web of Science ®Google Scholar
• Fouad SA, Basalious EB, El-Nabarawi MA, Tayel SA. (2013). Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Int J Pharm 453:569–78
   PubMed Web of Science ®Google Scholar
• Fu J, Feng X, Yuan H, et al. (2008). Study of ocular pharmacokinetics of in situ gel system for S(-)-satropane evaluated by microdialysis. J Pharm Biomed Anal 48:840–3
   PubMed Web of Science ®Google Scholar
• Gan L, Gan Y, Zhu C, et al. (2009). Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results. Int J Pharm 365:143–9
   PubMed Web of Science ®Google Scholar
• Ge S, Lin Y, Lu H, et al. (2014). Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction. Int J Pharm 465:120–31
   PubMed Web of Science ®Google Scholar
• Gong L, Sun XH, Qiu XD, et al. (2010). [Comparative research of the efficacy of the gatifloxacin and levofloxacin for bacterial conjunctivitis in human eyes]. Zhonghua Yan Ke Za Zhi 46:525–31
   PubMedGoogle Scholar
• Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. (2010). Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces 81:412–21
   PubMed Web of Science ®Google Scholar
• Ibrahim SS, Awad GA, Geneidi A, Mortada ND. (2009). Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release. Colloids Surf B Biointerfaces 69:225–31
   PubMed Web of Science ®Google Scholar
• Jain GK, Jain N, Pathan SA, et al. (2010). Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles. J Pharm Biomed Anal 52:110–13
   PubMed Web of Science ®Google Scholar
• Jiao J. (2008). Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev 60:1663–73
   PubMed Web of Science ®Google Scholar
• Jukanti R, Gaddam P, Jalagam M, Bandari S. (2011). Transcorneal permeation of ciprofloxacin liposomes: effect of surface charge and nonionic surfactants. J Disp Sci Technol 32:935–42
   Web of Science ®Google Scholar
• Kalam MA, Sultana Y, Ali A, et al. (2013). Part II: enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. J Biomed Mater Res A 101:1828–36
   PubMed Web of Science ®Google Scholar
• Kalam MA, Sultana Y, Samad A, et al. (2008). Gelrite-based in vitro gelation ophthalmic drug delivery system of gatifloxacin. J Disp Sci Technol 29:89–96
   Web of Science ®Google Scholar
• Kaur IP, Smitha R. (2002). Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 28:353–69
   PubMed Web of Science ®Google Scholar
• Kawakami K, Yoshikawa T, Moroto Y, et al. (2002). Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. J Control Release 81:65–74
   PubMed Web of Science ®Google Scholar
• Kesavan K, Pandit JK, Kant S, Muthu MS. (2013). Positively charged microemulsions of dexamethasone: comparative effects of two cosurfactants on ocular drug delivery and bioavailability. Ther Deliv 4:1385–95
   PubMedGoogle Scholar
• Kizilbash N, Asif S, Nazar M, et al. (2011). Design of a microemulsion-based drug delivery system for diclofenac sodium. J Chem Soc Pak 33:1–6
   Web of Science ®Google Scholar
• Kommuru TR, Gurley B, Khan MA, Reddy IK. (2001). Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 212:233–46
   PubMed Web of Science ®Google Scholar
• Kozai S, Wada T, Kida T, et al. (2009). Effect of dosing interval on the efficacy of topical ophthalmic gatifloxacin against Enterococcus faecalis in an in vitro pharmacokinetic model simulating the local eye compartment. Int J Antimicrob Agents 34:561–5
   PubMed Web of Science ®Google Scholar
• Kuntsche J, Klaus K, Steiniger F. (2009). Size determinations of colloidal fat emulsions: a comparative study. J Biomed Nanotechnol 5:384–95
   PubMed Web of Science ®Google Scholar
• Lee CH, Lee KJ, Yun I, Shin YH. (1991). Studies on corneal penetration of p-hydroxybenzoic acid esters. Arch Pharm Res 14:311–18
   Google Scholar
• Levine JM, Noecker RJ, Lane LC, et al. (2004). Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refract Surg 30:2177–82
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. (2007). Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 340:153–62
   PubMed Web of Science ®Google Scholar
• Liu Z, Li J, Nie S, et al. (2006). Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J Pharm Pharmacol 58:45–50
   PubMed Web of Science ®Google Scholar
• Liu Z, Pan W, Nie S, et al. (2005). Preparation and evaluation of sustained ophthalmic gel of enoxacin. Drug Dev Ind Pharm 31:969–75
   PubMed Web of Science ®Google Scholar
• Lutsar I, Friedland IR, Wubbel L, et al. (1998). Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 42:2650–5
   PubMed Web of Science ®Google Scholar
• Lv FF, Li N, Zheng LQ, Tung CH. (2006). Studies on the stability of the chloramphenicol in the microemulsion free of alcohols. Eur J Pharm Biopharm 62:288–94
   PubMed Web of Science ®Google Scholar
• Lv FF, Zheng LQ, Tung CH. (2005). Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. Int J Pharm 301:237–46
   PubMed Web of Science ®Google Scholar
• Mathiowitz E. (1999). Encyclopedia of controlled drug delivery. : John Wiley & Sons, Inc
   Google Scholar
• Mohanty B, Mishra SK, Majumdar DK. (2013). Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops. J Adv Pharm Technol Res 4:210–16
   PubMedGoogle Scholar
• Patel UL, Chotai NP, Nagda CD. (2012). Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: in vitro and in vivo evaluation. Pharm Dev Technol 17:15–22
   PubMed Web of Science ®Google Scholar
• Pokharkar V, Patil V, Mandpe L. (2014). Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery. Drug Deliv. [Epub ahead of print] [PMID 24601827]
   PubMed Web of Science ®Google Scholar
• Price MO, Price FW Jr., Maclellan D. (2005). Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens. J Cataract Refract Surg 31:2137–41
   PubMed Web of Science ®Google Scholar
• Rathore MS, Majumdar DK. (2006). Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech 7:E12–E17. Published online Jul 7, 2006. doi: 10.1208/pt070357
   PubMed Web of Science ®Google Scholar
• Shen J, Deng Y, Jin X, et al. (2010). Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution. Int J Pharm 402:248–53
   PubMed Web of Science ®Google Scholar
• Shokri J, Azarmi S, Fasihi Z, et al. (2012). Effects of various penetration enhancers on percutaneous absorption of piroxicam from emulgels. Res Pharm Sci 7:225–34
   PubMedGoogle Scholar
• Silva NC, Silva S, Sarmento B, Pintado M. (2013). Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis. Drug Deliv [Epub ahead of print] [PMID 24266551]
   PubMed Web of Science ®Google Scholar
• Srividya B, Cardoza RM, Amin PD. (2001). Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 73:205–11
   PubMed Web of Science ®Google Scholar
• Sultana Y, Aqil M, Ali A. (2005). Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation. Acta Pharm 55:305–14
   PubMedGoogle Scholar
• Tiffany JM, Winter N, Bliss G. (1989). Tear film stability and tear surface tension. Curr Eye Res 8:507–15
   PubMed Web of Science ®Google Scholar
• Trotta M. (1999). Influence of phase transformation on indomethacin release from microemulsions. J Control Release 60:399–405
   PubMed Web of Science ®Google Scholar
• Verma P, Gupta RN, Jha AK, Pandey R. (2013). Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide. Drug Deliv 20:269–76
   PubMed Web of Science ®Google Scholar
• Washington N, Washington C, WIlson C. (2001). Ocular drug delivery. In: Washington N, Washington C, WIlson C, ed. Physiological pharmaceutics: barriers to drug absorption. : Taylors and Francis, 249–70
   Google Scholar
• Wei G, Xu H, Ding PT, et al. (2002). Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release 83:65–74
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. (2010). PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 99:306–14
   PubMed Web of Science ®Google Scholar
• Zimmer A, Kreuter J. (1995). Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 16:61–73
   Web of Science ®Google Scholar